Catalog Home Page

Publications: Wilton, Steve

Stats for Wilton, Steve
Export as [feed] RSS
Group by: Item Type | Year
Number of items: 270.

Journal Article

Martinovich, K.M., Kicic, A., Fletcher, S., Wilton, S.D. and Stick, S.M. (2019) Antisense oligonucleotides to improve CFTR function for people with the INTRON 9 5T polymorphism. Pediatric Pulmonology, 54 (S2). S217-S218.

Pitout, I., Flynn, L.L., Wilton, S.D. and Fletcher, S. (2019) Antisense-mediated splice intervention to treat human disease: the odyssey continues. F1000Research, 8 .

Keegan, N.P., Wilton, S.D. and Fletcher, S. (2019) Breakpoint junction features of seven DMD deletion mutations. Human Genome Variation, 6 (1).

Aung-Htut, M.T., McIntosh, C.S., West, K.A., Fletcher, S. and Wilton, S.D. (2019) In Vitro Validation of Phosphorodiamidate Morpholino Oligomers. Molecules, 24 (16). p. 2922.

Aung-Htut, M.T., Comerford, I., Johnsen, R., Foyle, K., Fletcher, S. and Wilton, S.D. (2019) Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides. Scientific Reports, 9 (1).

Callus, B.A., Finch-Edmondson, M.L., Fletcher, S. and Wilton, S.D. (2019) YAPping about and not forgetting TAZ. FEBS Letters, 593 (3). pp. 253-276.

Bolduc, V, Foley, A.R., Solomon-Degefa, H., Sarathy, A., Donkervoort, S., Hu, Y., Chen, G.S., Sizov, K., Nalls, M., Zhou, H., Aguti, S., Cummings, B.B., Lek, M., Tukiainen, T., Marshall, J.L., Regev, O., Marek-Yagel, D., Sarkozy, A., Butterfield, R.J., Jou, C., Jimenez-Mallebrera, C., Li, Y., Gartioux, C., Mamchaoui, K., Allamand, V., Gualandi, F., Ferlini, A., Hanssen, E., Wilton, S.D., Lamandé, S.R., MacArthur, D.G., Wagener, R., Muntoni, F. and Bönnemann, C.G. (2019) A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies. JCI Insight, 4 (6). art. no. e124403.

West, K.A., Fletcher, S. and Wilton, S.D. (2018) Antisense oligonnucleotide treatment of COL7A1 causes non-specific splice modifications. Journal of Gene Medicine, 20 (1).

Flynn, L.L., Mitrpant, C., Pitout, I.L., Fletcher, S. and Wilton, S.D. (2018) Antisense oligonucleotide mediated terminal intron retention of the SMN2 transcript. Molecular Therapy - Nucleic Acids, 11 . pp. 91-102.

Le, B.T., Raguraman, P., Kosbar, T.R., Fletcher, S., Wilton, S.D. and Veedu, R.N. (2018) Antisense oligonucleotides targeting angiogenic factors as potential cancer therapeutics. Molecular Therapy - Nucleic Acids, 14 (1). pp. 142-157.

Bao, L.T., Herdewijn, P., Filichev, V.V., Wilton, S.D., Fletcher, S. and Veedu, R.N. (2018) Exploring novel therapeutic chemistries in exon-skipping for duchenne muscular dystrophy. Journal of Gene Medicine, 20 (1).

Aung-Htut, M.T., West, K., Barrett, L., Cardwell, K., Schnell, F.J., Fletcher, S. and Wilton, S.D. (2018) Late onset Pompe disease: Rescue of acid alpha-glucosidase expression by splice modification. Journal of Gene Medicine, 20 (1).

Greer, K., Fletcher, S. and Wilton, S.D. (2018) Multiple exon skipping to correct duplications in the dystrophin gene. Journal of Gene Medicine, 20 (1).

Wilton, S.D. (2018) Pre-MRNA splicing as a therapy for duchenne muscular dystrophy. Journal of Gene Medicine, 20 (1).

Li, D., Mastaglia, F.L., Fletcher, S. and Wilton, S.D. (2018) Precision medicine through antisense oligonucleotide-mediated exon skipping. Trends in Pharmacological Sciences, 39 (11). pp. 982-994.

Martinovich, K.M., Wilton, S.D., Fletcher, S., Kicic, A. and Stick, S.M. (2018) Rescue of CFTR function impaired by mutations in EXON 15 in children with cyctic fibrosis. Pediatric Pulmonology, 53 (S2). S224-S224.

Martinovich, K.M., Kicic, A., Fletcher, S., Wilton, S.D. and Stick, S.M. (2018) Rescuing CFTR function caused by mutation specific polymorphisms in cystic fibrosis patients. The Journal of Gene Medicine, 20 (1).

Li, D.H., Greer, K., West, K., Addams, A., Fletcher, S. and Wilton, S. (2018) Small chemical modulation of induced alternative splicing. Journal of Gene Medicine, 20 (1).

Martinovich, K.M., Shaw, N.C., Kicic, A., Schultz, A., Fletcher, S., Wilton, S.D. and Stick, S.M. (2018) The potential of antisense oligonucleotide therapies for inherited childhood lung diseases. Molecular and Cellular Pediatrics, 5 (1).

McIntosh, C.S., Aung-Htut, M.T., Fletcher, S. and Wilton, S.D. (2018) The use of antisense oligonucleotide-mediated exon skipping to treat spinocerebellar ataxia type 3. Journal of Gene Medicine, 20 (1).

Bellgard, M.I., Chartres, N., Watts, G.F., Wilton, S., Fletcher, S., Hunter, A. and Snelling, T. (2017) Comprehending the health informatics spectrum: Grappling with system entropy and advancing quality clinical research. Frontiers in Public Health, 5 .

Wein, N., Vulin, A., Findlay, A.R., Gumienny, F., Huang, N., Wilton, S.D. and Flanigan, K.M. (2017) Efficient skipping of single exon duplications in DMD Patient-Derived cell lines using an antisense oligonucleotide approach. Journal of Neuromuscular Diseases, 4 (3). pp. 199-207.

Fraidenraich, D., Mishra, M.K., Loro, E., Sengupta, K., Wilton, S.D. and Khurana, T.S. (2017) Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction. PLoS ONE, 12 (10).

Huang, D., Fletcher, S., Wilton, S., Palmer, N., McLenachan, S., Mackey, D. and Chen, F. (2017) Inherited retinal disease therapies targeting precursor messenger ribonucleic acid. Vision, 1 (3). p. 22.

Wilton, S. and Fletcher, S. (2017) Making sense in Duchenne muscular dystrophy: Slowing the natural progression of muscle wasting. Journal of the Neurological Sciences, 381 (Supp.). p. 58.

Le, B.T., Adams, A.M., Fletcher, S., Wilton, S.D. and Veedu, R.N. (2017) Rational design of short locked Nucleic Acid-Modified 2′- O -Methyl antisense oligonucleotides for efficient exon-skipping in vitro. Molecular Therapy - Nucleic Acids, 9 . pp. 155-161.

Muntoni, F., Fletcher, S. and Wilton, S. (2017) Response to “Railroading at the FDA". Nature Biotechnology, 35 (3). pp. 207-209.

Fletcher, S., Bellgard, M.I., Price, L., Akkari, A.P. and Wilton, S.D. (2017) Translational development of splice-modifying antisense oligomers. Expert Opinion on Biological Therapy, 17 (1). pp. 15-30.

Thygesen, S.J, Sester, D.P., Cridland, S.O., Wilton, S.D. and Stacey, K.J. (2016) Correcting the NLRP3 inflammasome deficiency in macrophages from autoimmune NZB mice with exon skipping antisense oligonucleotides. Immunology and Cell Biology, 94 (5). pp. 520-524.

Fraidenraich, D., Toh, Z.Y.C., Aung-Htut, M.T., Pinniger, G., Adams, A.M., Krishnaswarmy, S., Wong, B.L., Fletcher, S. and Wilton, S.D. (2016) Deletion of dystrophin In-Frame Exon 5 leads to a severe phenotype: Guidance for Exon skipping strategies. PloS one, 11 (1). e0145620.

Weiss, D.J., Rasko, J.E.J., Cuende, N., Ruiz, M.A., Ho, H-N, Nordon, R., Wilton, S., Dominici, M. and Srivastava, A. (2016) Part 2: Making the “unproven” “proven". Cytotherapy, 18 (1). pp. 120-123.

Bao, T.L., Veedu, R.N., Fletcher, S. and Wilton, S.D. (2015) Antisense oligonucleotide development for the treatment of muscular dystrophies. Expert Opinion on Orphan Drugs, 4 (2). pp. 139-152.

Dominici, M., Nichols, K., Srivastava, A., Weiss, D.J., Eldridge, P., Cuende, N., Deans, R.J., Rasko, J.E.J., Levine, A.D., Turner, L., Griffin, D.L., O'Donnell, L., Forte, M., Mason, C., Wagena, E., Janssen, W., Nordon, R., Wall, D., Ho, H-N, Ruiz, M.A., Wilton, S., Horwitz, E.M. and Gunter, K.C. (2015) Positioning a scientific community on unproven cellular therapies: The 2015 International Society for Cellular Therapy Perspective. Cytotherapy, 17 (12). pp. 1663-1666.

Greer, K., Mizzi, K., Rice, E., Kuster, L., Barrero, R.A., Bellgard, M.I., Lynch, B.J., Foley, A.R., O Rathallaigh, E., Wilton, S.D. and Fletcher, S. (2015) Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient. Molecular Genetics & Genomic Medicine, 3 (4). pp. 320-326.

Aaldering, L.J., Tayeb, H., Krishnan, S., Fletcher, S., Wilton, S.D. and Veedu, R.N. (2015) Smart functional nucleic acid chimeras: Enabling tissue specific RNA targeting therapy. RNA Biology, 12 (4). pp. 412-425.

Wilton, S.D., Veedu, R.N. and Fletcher, S. (2015) The emperor's new dystrophin: Finding sense in the noise. Trends in Molecular Medicine, 21 (7). pp. 417-426.

Stirnweiss, A., McCarthy, K., Oommen, J., Crook, M.L., Hardy, K., Kees, U.R., Wilton, S.D., Anazodo, A. and Beesley, A.H. (2015) A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma. Oncogenesis, 4 (11). e174.

Bellgard, M.I., Napier, K., Render, L., Radochonski, M., Lamont, L., Graham, C., Wilton, S.D., Fletcher, S., Goldblatt, J., Hunter, A.A. and Weeramanthri, T. (2015) A registry framework enabling patient-centred care. Studies in Health Technology and Informatics, 214 . pp. 8-14.

de la Kethulle de Ryhove, L., Ansseau, E., Nachtegael, C., Pieters, K., Vanderplanck, C., Geens, M., Sermon, K., Wilton, S.D., Coppée, F., Lagneaux, L. and Belayew, A. (2015) The role of D4Z4-Encoded proteins in the osteogenic differentiation of Mesenchymal Stromal cells isolated from bone marrow. Stem Cells and Development, 24 (22). pp. 2674-2686.

Luo, Y-B, Mitrpant, C., Adams, A.M., Johnsen, R.D., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2014) Antisense oligonucleotide induction of progerin in human myogenic cells. PLoS ONE, 9 (6).

Wilton, S.D., Fletcher, S. and Flanigan, K.M. (2014) Dystrophin as a therapeutic biomarker: Are we ignoring data from the past? Neuromuscular Disorders, 24 (6). pp. 463-466.

Luo, Y-B, Mastaglia, F.L. and Wilton, S.D. (2014) Normal and aberrant splicing of LMNA. Journal of Medical Genetics, 51 (4). pp. 215-223.

Bellgard, M.I., Sleeman, M.W., Guerrero, F.D., Fletcher, S., Baynam, G., Goldblatt, J., Rubinstein, Y., Bell, C., Groft, S., Barrero, R., Bittles, A.H., Wilton, S.D., Mason, C.E. and Weeramanthri, T. (2014) Rare disease research roadmap: Navigating the bioinformatics and translational challenges for improved patient health outcomes. Health Policy and Technology, 3 (4). pp. 325-335.

Wein, N., Vulin, A., Falzanaro, M.S., Szigyarto, C.A.K., Maiti, B., Findlay, A., Heller, K.N., Uhlen, M., Bakthavachalu, B., Messina, S., Vita, G.L., Gualandi, F., Wilton, S.D., Yang, L., Dunn, D.M., Schoenberg, D., Weiss, R.B., Howard, M.T., Ferlini, A. and Flanigan, K.M. (2014) Successful use of Out-of-Frame Exon 2 Skipping induces IRES-Driven expression of the N-Truncated dystrophin isoform: promising approach for treating other 5 ' Dystrophin Mutations. Molecular Therapy, 22 (Supp. 1). S294-S295.

Greer, K.L., Lochmüller, H., Flanigan, K., Fletcher, S. and Wilton, S.D. (2014) Targeted exon skipping to correct exon duplications in the dystrophin gene. Molecular Therapy — Nucleic Acids, 3 (3). e155.

Wein, N., Vulin, A., Falzarano, M.S., Szigyarto, C.A-K., Maiti, B., Findlay, A., Heller, K.N., Uhlén, M., Bakthavachalu, B., Messina, S., Vita, G., Passarelli, C., Gualandi, F., Wilton, S.D., Rodino-Klapac, L.R., Yang, L., Dunn, D.M., Schoenberg, D.R., Weiss, R.B., Howard, Michael T, Ferlini, Alessandra and Flanigan, Kevin M (2014) Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice. Nature Medicine, 20 (9). pp. 992-1000.

Rojana-udomsart, A., Mitrpant, C., James, I., Witt, C., Needham, M., Day, T., Kiers, L., Corbett, A., Martinez, P., Wilton, S.D. and Mastaglia, F.L. (2013) Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis. Journal of Neuroimmunology, 254 (1-2). pp. 174-177.

Fletcher, S., Meloni, P.L., Johnsen, R.D., Wong, B.L., Muntoni, F. and Wilton, S.D. (2013) Antisense suppression of donor splice site mutations in the dystrophin gene transcript. Molecular Genetics & Genomic Medicine, 1 (3). pp. 162-173.

Rojana-udomsart, A., Mitrpant, C., Bundell, C., Price, L., Luo, Y-B, Fabian, V., Wilton, S.D., Hollingsworth, P. and Mastaglia, F.L. (2013) Complement-mediated muscle cell lysis: A possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM). Journal of Neuroimmunology, 264 (1-2). pp. 65-70.

Krishnaswamy, S., Fletcher, S., Wong, B.L. and Wilton, S.D. (2013) Exceptions to exceptions in the Duchenne: Becker dystrophin reading frame. The Journal of Gene Medicine, 15 (8-9). p. 336.

Fletcher, S. and Wilton, S.D. (2013) Exon skipping and Duchenne muscular dystrophy: A clinical trial update. The Journal of Gene Medicine, 15 (8-9). p. 330.

Buratti, E., Mitrpant, C., Porensky, P., Zhou, H., Price, L., Muntoni, F., Fletcher, S., Wilton, S.D. and Burghes, A.H.M. (2013) Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: Towards a treatment for spinal muscular atrophy. PLoS ONE, 8 (4). e62114.

Luo, Y-B, Mitrpant, C., Johnsen, R.D., Fabian, V.A., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2013) Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles. International Journal of Clinical and Experimental Pathology, 6 (12). pp. 2778-2786.

Luo, Y-B, Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. International Journal of Clinical and Experimental Pathology, 6 (9). pp. 1723-1733.

Plummer, P.N., Freeman, R., Taft, R.J., Vider, J., Sax, M., Umer, B.A., Gao, D., Johns, C, Mattick, J.S., Wilton, S.D., Ferro, V., McMillan, N.A.J., Swarbrick, A., Mittal, V. and Mellick, A.S. (2013) MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Research, 73 (1). pp. 341-352.

Fletcher, S., Viola, H.M., Adams, A.M., Wilton, S.D. and Hool, L.C. (2013) P.11.5 PMO-mediated dystrophin exon 23 skipping restores mitochondrial function in the mdx mouse heart. Neuromuscular Disorders, 23 (9-10). p. 800.

Luo, Y-B, Johnsen, R.D., Griffiths, L., Needham, M., Fabian, V.A., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse. International Journal of Experimental Pathology, 94 (6). pp. 418-425.

Fraidenraich, D., Pigozzo, S.R., Da Re, L., Romualdi, C., Mazzara, P.G., Galletta, E., Fletcher, S., Wilton, S.D. and Vitiello, L. (2013) Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related reappraisal. PLoS ONE, 8 (8). e72147.

Tremblay, J.P., Xiao, X., Aartsma-Rus, A., Barbas, C., Blau, H.M., Bogdanove, A.J., Boycott, K., Braun, S., Breakefield, X.O., Bueren, J.A., Buschmann, M., Byrne, B.J., Calos, M., Cathomen, T., Chamberlain, J., Chuah, M., Cornetta, K., Davies, K.E., Dickson, J.G., Duchateau, P., Flotte, T.R., Gaudet, D., Gersbach, C.A., Gilbert, R., Glorioso, J., Herzog, R.W., High, K.A., Huang, W., Huard, J., Joung, J.K., Liu, D., Liu, D., Lochmüller, H., Lustig, L., Martens, J., Massie, B., Mavilio, F., Mendell, J.R., Nathwani, A., Ponder, K., Porteus, M., Puymirat, J., Samulski, J., Takeda, S., Thrasher, A., VandenDriessche, T., Wei, Y., Wilson, J.M., Wilton, S.D., Wolfe, J.H. and Gao, G. (2013) Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases. Molecular Therapy, 21 (2). pp. 266-268.

Moorwood, C., Soni, N., Patel, G., Wilton, S.D. and Khurana, T.S. (2013) A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation. Journal of Biomolecular Screening, 18 (4). pp. 400-406.

Qiu, W., Pham, K., James, I., Nolan, D., Castley, A., Christiansen, F.T., Czarniak, P., Luo, Y., Wu, J., Garlepp, M., Wilton, S., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. Journal of Neuroimmunology, 261 (1-2). pp. 92-97.

Zhou, H., Janghra, N., Mitrpant, C., Dickinson, R.L., Anthony, K., Price, L., Eperon, I.C., Wilton, S.D., Morgan, J. and Muntoni, F. (2013) A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice. Human Gene Therapy, 24 (3). pp. 331-342.

Wilton, S. (2013) An update on DMD exon skipping trials: Making more sense with splice switching antisense oligonucleotides. Clinical and Experimental Pharmacology and Physiology, 40 (Supp. 1). p. 38.

Anderton, R.S., Price, L.L., Turner, B.J., Meloni, B.P., Mitrpant, C., Mastaglia, F.L., Goh, C., Wilton, S.D. and Boulos, S. (2012) Co-regulation of survival of motor neuron and Bcl-xL expression: Implications for neuroprotection in spinal muscular atrophy. Neuroscience, 220 . pp. 228-236.

Adkin, C.F., Meloni, P.L., Fletcher, S., Adams, A.M., Muntoni, F., Wong, B. and Wilton, S.D. (2012) Multiple exon skipping strategies to by-pass dystrophin mutations. Neuromuscular Disorders, 22 (4). pp. 297-305.

Barrett, L.W., Fletcher, S. and Wilton, S.D. (2012) Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cellular and Molecular Life Sciences, 69 (21). pp. 3613-3634.

Fletcher, S., Adkin, C.F., Meloni, P., Wong, B., Muntoni, F., Kole, R., Fragall, C., Greer, K., Johnsen, R. and Wilton, S.D. (2012) Targeted exon skipping to address “Leaky” mutations in the dystrophin gene. Molecular Therapy — Nucleic Acids, 1 (10). e48.

Porensky, P.N., Mitrpant, C., McGovern, V.L., Bevan, A.K., Foust, K.D., Kaspar, B.K., Wilton, S.D. and Burghes, A.H.M. (2012) A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse. Human Molecular Genetics, 21 (7). pp. 1625-1638.

Pichavant, C., Aartsma-Rus, A., Clemens, P.R., Davies, K.E., Dickson, G., Takeda, S., Wilton, S.D., Wolff, J.A., Wooddell, C.I., Xiao, X. and Tremblay, J.P. (2011) Current Status of Pharmaceutical and Genetic Therapeutic Approaches to Treat DMD. Molecular Therapy, 19 (5). pp. 830-840.

Berger, J., Berger, S., Jacoby, A.S., Wilton, S.D. and Currie, P.D. (2011) Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish. Journal of Cellular and Molecular Medicine, 15 (12). pp. 2643-2651.

Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M.E., Bourke, J., Wells, D.J., Dickson, G., Wood, M.J.A., Wilton, S.D., Straub, V., Kole, R., Shrewsbury, S.B., Sewry, C., Morgan, J.E., Bushby, K. and Muntoni, F. (2011) Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study. The Lancet, 378 (9791). pp. 595-605.

Chadwick, B.P., Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton, S.D., Coppée, F. and Belayew, A. (2011) The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS ONE, 6 (10). e26820.

Both, G., Alexander, I., Fletcher, S., Nicolson, T.J., Rasko, J.E.J., Wilton, S.D. and Symonds, G. (2011) Gene therapy: Therapeutic applications and relevance to pathology. Pathology, 43 (6). pp. 642-656.

Fragall, C.T., Adams, A.M., Johnsen, R.D., Kole, R., Fletcher, S. and Wilton, S.D. (2011) Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching. BMC Medical Genetics, 12 (1).

Laing, N.G., Davis, M.R., Bayley, K., Fletcher, S. and Wilton, S.D. (2011) Molecular diagnosis of Duchenne muscular dystrophy: Past, present and future in relation to implementing therapies. The Clinical Biochemist: Reviews, 32 (3). pp. 129-134.

Wilton, S.D. and Fletcher, S. (2011) RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic Outcomes. Current Gene Therapy, 11 (4). pp. 259-275.

Wilber, A.C., Basu, U., Lozynska, O., Moorwood, C., Patel, G., Wilton, S.D. and Khurana, T.S. (2011) Translational Regulation of Utrophin by miRNAs. PloS one, 6 (12). e29376.

Popplewell, L.J., Adkin, C., Arechavala-Gomeza, V., Aartsma-Rus, A., de Winter, C.L., Wilton, S.D., Morgan, J.E., Muntoni, F., Graham, I.R. and Dickson, G. (2010) Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials. Neuromuscular Disorders, 20 (2). pp. 102-110.

Fletcher, S., Adams, A.M., Johnsen, R.D., Greer, K., Moulton, H.M. and Wilton, S.D. (2010) Dystrophin isoform induction In Vivo by Antisense-mediated alternative splicing. Molecular Therapy, 18 (6). pp. 1218-1223.

Zhou, Z., Lau, J.Y., Oliver, B.G., Baraket, M., Beckett, E.L., Hansbro, N.G., Moir, L.M., Wilton, S.D., Williams, C., Foster, P.S., Hansbro, P.M., Black, J.L. and Burgess, J.K. (2010) Fibulin-1 is increased in asthma – A novel mediator of airway remodeling? PloS one, 5 (10). e13360.

Forrest, S., Meloni, P.L., Muntoni, F., Kim, J., Fletcher, S. and Wilton, S.D. (2010) Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations. Neuromuscular Disorders, 20 (12). pp. 810-816.

Goyenvalle, A., Babbs, A., Powell, D., Kole, R., Fletcher, S., Wilton, S.D. and Davies, K.E. (2010) Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping. Molecular Therapy, 18 (1). pp. 198-205.

Wilton, S. and Fletcher, S. (2010) Splice modification to restore functional dystrophin synthesis in duchenne muscular dystrophy. Current Pharmaceutical Design, 16 (8). pp. 988-1001.

Mitrpant, C., Fletcher, S., Iversen, P.L. and Wilton, S.D. (2009) By-passing the nonsense mutation in the 4CV mouse model of muscular dystrophy by induced exon skipping. The Journal of Gene Medicine, 11 (1). pp. 46-56.

Madden, H.R., Fletcher, S., Davis, M.R. and Wilton, S.D. (2009) Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping. Human Mutation, 30 (1). pp. 22-28.

Sutherland, G.T., Halliday, G.M., Silburn, P.A., Mastaglia, F.L., Rowe, D.B., Boyle, R.S., O'Sullivan, J.D., Ly, T., Wilton, S.D. and Mellick, G.D. (2009) Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? Movement Disorders, 24 (6). pp. 833-838.

Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S., Hunt, D., Adkin, C., Guglieri, M., Ashton, E., Abbs, S., Nihoyannopoulos, P., Garralda, M.E., Rutherford, M., Mcculley, C., Popplewell, L., Graham, I.R., Dickson, G., Wood, M.J.A., Wells, D.J., Wilton, S.D., Kole, R., Straub, V., Bushby, K., Sewry, C., Morgan, J.E. and Muntoni, F. (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. The Lancet Neurology, 8 (10). pp. 918-928.

Mitrpant, C., Fletcher, S. and Wilton, S. (2009) Personalised genetic intervention for duchenne muscular dystrophy: Antisense oligomers and exon skipping. Current Molecular Pharmacology, 2 (1). pp. 110-121.

Doran, P., Wilton, S.D., Fletcher, S. and Ohlendieck, K. (2009) Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics, 9 (3). pp. 671-685.

Mitrpant, C., Adams, A.M., Meloni, P.L., Muntoni, F., Fletcher, S. and Wilton, S.D. (2009) Rational design of antisense oligomers to induce dystrophin exon skipping. Molecular Therapy, 17 (8). pp. 1418-1426.

Gurvich, O.L., Tuohy, T.M., Howard, M.T., Finkel, R.S., Medne, L., Anderson, C.B., Weiss, R.B., Wilton, S.D. and Flanigan, K.M. (2008) DMD pseudoexon mutations: Splicing efficiency, phenotype, and potential therapy. Annals of Neurology, 63 (1). pp. 81-89.

Wilton, S.D. and Fletcher, S. (2008) Exon skipping and Duchenne muscular dystrophy: Hope, hype and how feasible? Neurology India, 56 (3). pp. 254-262.

Wilton, S. (2008) Exon skipping in Duchenne muscular dystrophy. Neuromuscular Disorders, 18 (5). pp. 431-432.

Laws, N., Cornford-Nairn, R.A., Irwin, N., Johnsen, R., Fletcher, S., Wilton, S.D. and Hoey, A.J. (2008) Long-term administration of antisense oligonucleotides into the paraspinal muscles of mdx mice reduces kyphosis. Journal of Applied Physiology, 105 (2). pp. 662-668.

Wilton, S. and Fletcher, S. (2008) T.I.4 Splice manipulation therapies: Opportunities and challenges. Neuromuscular Disorders, 18 (9-10). p. 831.

Wilton, S., Mitrpant, C., Meloni, P., Adams, A. and Fletcher, S. (2008) T.P.2.01 Antisense oligomer design: Targeting and assay systems. Neuromuscular Disorders, 18 (9-10). p. 756.

Fletcher, S., Davis, M., MADDEN, H. and Wilton, S. (2008) T.P.2.03 Characterisation of a complex dystrophin mutation: Assume nothing when designing exon skipping strategies. Neuromuscular Disorders, 18 (9-10). p. 757.

Fletcher, S., Steinhaus, J., Mitrpant, C., Meloni, P. and Wilton, S. (2008) T.P.2.09 Induced exon skipping in normal and mdx muscle. Neuromuscular Disorders, 18 (9-10). pp. 758-759.

Wilton, S.D., Fall, A.M., Harding, P.L., McClorey, G., Coleman, C. and Fletcher, S. (2007) Antisense Oligonucleotide-induced exon skipping across the human dystrophin gene transcript. Molecular Therapy, 15 (7). pp. 1288-1296.

Adams, A.M., Harding, P.L., Iversen, P.L., Coleman, C., Fletcher, S. and Wilton, S.D. (2007) Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: Cocktails and chemistries. BMC Molecular Biology, 8 (1).

Fletcher, S., Moulton, H.M., Neuman, B.W., McClorey, G., Stein, D.A., Abes, S., Wilton, S.D., Buchmeier, M.J., Lebleu, B. and Iversen, P.L. (2007) Cell-penetrating peptide–morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo. Biochemical Society Transactions, 35 (4). pp. 826-828.

Arechavala-Gomeza, V., Graham, I.R., Popplewell, L.J., Adams, A.M., Aartsma-Rus, A., Kinali, M., Morgan, J.E., van Deutekom, J.C., Wilton, S.D., Dickson, G. and Muntoni, F. (2007) Comparative analysis of antisense oligonucleotide sequences for targeted skipping of Exon 51 during dystrophin Pre-mRNA splicing in human muscle. Human Gene Therapy, 18 (9). pp. 798-810.

Fletcher, S., Honeyman, K., Fall, A.M., Harding, P.L., Johnsen, R.D., Steinhaus, J.P., Moulton, H.M., Iversen, P.L. and Wilton, S.D. (2007) Morpholino Oligomer–mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. Molecular Therapy, 15 (9). pp. 1587-1592.

Webb, B.T., Oord, E., Akkari, A., Wilton, S., Ly, T., Duff, R., Barnes, K.C., Carlsen, K., Gerritsen, J., Lenney, W., Silverman, M., Sly, P., Sundy, J., Tsanakas, J., Berg, A., Whyte, M., Blumenthal, M., Vestbo, J., Middleton, L., Helms, P.J., Anderson, W.H. and Pillai, S.G. (2007) Quantitative linkage genome scan for atopy in a large collection of Caucasian families. Human Genetics, 121 (1). pp. 83-92.

Harding, P.L., Fall, A.M., Honeyman, K., Fletcher, S. and Wilton, S.D. (2007) The influence of antisense oligonucleotide length on dystrophin exon skipping. Molecular Therapy, 15 (1). pp. 157-166.

Wilton, S.D. and Fletcher, S. (2006) Modification of pre-mRNA processing: Application to dystrophin expression. Current Opinion in Molecular Therapeutics, 8 (2). pp. 130-135.

McClorey, G., Moulton, H.M., Iversen, P.L., Fletcher, S. and Wilton, S.D. (2006) Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Therapy, 13 (19). pp. 1373-1381.

Fletcher, S., Honeyman, K., Fall, A.M., Harding, P.L., Johnsen, R.D. and Wilton, S.D. (2006) Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide. The Journal of Gene Medicine, 8 (2). pp. 207-216.

McClorey, G., Fall, A.M., Moulton, H.M., Iversen, P.L., Rasko, J.E., Ryan, M., Fletcher, S. and Wilton, S.D. (2006) Induced dystrophin exon skipping in human muscle explants. Neuromuscular Disorders, 16 (9-10). pp. 583-590.

Fall, A.M., Johnsen, R., Honeyman, K., Iversen, P., Fletcher, S. and Wilton, S.D. (2006) Induction of revertant fibres in the mdx mouse using antisense oligonucleotides. Genetic Vaccines and Therapy, 4 (1). p. 3.

Alter, J., Lou, F., Rabinowitz, A., Yin, H.F., Rosenfeld, J., Wilton, S.D., Partridge, T.A. and Lu, Q.L. (2006) Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nature Medicine, 12 (2). pp. 175-177.

Wilton, S.D. and Fletcher, S. (2005) Antisense oligonucleotides, exon skipping and the dystrophin gene transcript. Acta Myologica : Myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 24 (3). pp. 222-229.

Wilton, S.D. and Fletcher, S. (2005) Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now? Neuromuscular Disorders, 15 (6). pp. 399-402.

Yu, Y., Wyszynski, D.F., Waterworth, D.M., Wilton, S.D., Barter, P.J., Kesaniemi, Y.A., Mahley, R.W., McPherson, R., Waeber, G., Bersot, T.P., Ma, Q., Sharma, S.S., Montgomery, D.S., Middleton, L.T., Sundseth, S.S., Mooser, V., Grundy, S.M. and Farrer, L.A. (2005) Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. The Journal of Lipid Research, 46 (10). pp. 2202-2213.

Wilton, S. and Fletcher, S. (2005) RNA splicing manipulation: Strategies to modify gene expression for a variety of therapeutic outcomes. Current Gene Therapy, 5 (5). pp. 467-483.

McClorey, G., Fletcher, S. and Wilton, S. (2005) Splicing intervention for Duchenne muscular dystrophy. Current Opinion in Pharmacology, 5 (5). pp. 529-534.

Gebski, B.L., Errington, S.J., Johnsen, R.D., Fletcher, S. and Wilton, S.D. (2005) Terminal antisense oligonucleotide modifications can enhance induced exon skipping. Neuromuscular Disorders, 15 (9-10). pp. 622-629.

Wells, K.E., Fletcher, S., Mann, C.J., Wilton, S.D. and Wells, D.J. (2003) Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. FEBS Letters, 552 (2-3). pp. 145-149.

Lu, Q.L., Mann, C.J., Lou, F., Bou-Gharios, G., Morris, G.E., Xue, S-A, Fletcher, S., Partridge, T.A. and Wilton, S.D. (2003) Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse. Nature Medicine, 9 (8). pp. 1009-1014.

Gebski, B.L., Mann, C.J., Fletcher, S. and Wilton, S.D. (2003) Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Human Molecular Genetics, 12 (15). pp. 1801-1811.

Errington, S.J., Mann, C.J., Fletcher, S. and Wilton, S.D. (2003) Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene. The Journal of Gene Medicine, 5 (6). pp. 518-527.

Mann, C.J., Honeyman, K., McClorey, G., Fletcher, S. and Wilton, S.D. (2002) Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy. The Journal of Gene Medicine, 4 (6). pp. 644-654.

Mann, C.J., Honeyman, K., Cheng, A.J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J.E., Partridge, T.A. and Wilton, S.D. (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proceedings of the National Academy of Sciences of the United States of America, 98 (1). pp. 42-47.

Fletcher, S., Ly, T., Duff, R.M., Howell, J.Mc.C. and Wilton, S.D. (2001) Cryptic splicing involving the splice site mutation in the canine model of Duchenne muscular dystrophy. Neuromuscular Disorders, 11 (3). pp. 239-243.

Fletcher, S., Carville, K.S., Howell, J.M., Mann, C.J. and Wilton, S.D. (2001) Evaluation of a short interspersed nucleotide element in the 3' untranslated region of the defective dystrophin gene of dogs with muscular dystrophy. American Journal of Veterinary Research, 62 (12). pp. 1964-1968.

Loh, N.K., Woerly, S., Bunt, S.M., Wilton, S.D. and Harvey, A.R. (2001) The regrowth of axons within tissue defects in the CNS is promoted by implanted hydrogel matrices that contain BDNF and CNTF producing fibroblasts. Experimental Neurology, 170 (1). pp. 72-84.

Fletcher, S., Wilton, S.D. and Howell, J.Mc.C. (2000) Gene therapy and molecular approaches to the treatment of hereditary muscular disorders. Current Opinion in Neurology, 13 (5). pp. 553-560.

Lu, Q.L., Morris, G.E., Wilton, S.D., Ly, T., Artem'yeva, O.V., Strong, P. and Partridge, T.A. (2000) Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. The Journal of Cell Biology, 148 (5). pp. 985-996.

Nowak, K.J., Walsh, P., Jacob, R.L., Johnsen, R.D., Peverall, J., McNally, E.M., Wilton, S.D., Kakulas, B.A. and Laing, N.G. (2000) Severe γ-sarcoglycanopathy caused by a novel missense mutation and a large deletion. Neuromuscular Disorders, 10 (2). pp. 100-107.

Honeyman, K., Carville, K.S., Howell, J.M., Fletcher, S. and Wilton, S.D. (1999) Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele. American Journal of Veterinary Research, 60 (6). pp. 734-7.

Panegyres, P.K., Mamotte, C.D.S., Vasikaran, S.D., Wilton, S., Fabian, V. and Kakulas, B.A. (1999) Butyrylcholinesterase K variant and Alzheimer's disease. Journal of Neurology, 246 (5). pp. 369-370.

Tan, P., Briner, J., Boltshauser, E., Davis, M.R., Wilton, S.D., North, K., Wallgren-Pettersson, C. and Laing, N. (1999) Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscular Disorders, 9 (8). pp. 573-579.

Schatzberg, S.J., Olby, N.J., Breen, M., Anderson, L.V.B., Langford, C.F., Dickens, H.F., Wilton, S.D., Zeiss, C.J., Binns, M.M., Kornegay, J.N., Morris, G.E. and Sharp, N.J.H. (1999) Molecular analysis of a spontaneous dystrophin `knockout' dog. Neuromuscular Disorders, 9 (5). pp. 289-295.

Pelin, K., Hilpela, P., Donner, K., Sewry, C., Akkari, P.A., Wilton, S.D., Wattanasirichaigoon, D., Bang, M-L, Centner, T., Hanefeld, F., Odent, S., Fardeau, M., Urtizberea, J.A., Muntoni, F., Dubowitz, V., Beggs, A.H., Laing, N.G., Labeit, S., de la Chapelle, A. and Wallgren-Pettersson, C. (1999) Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proceedings of the National Academy of Sciences, 96 (5). pp. 2305-2310.

Mastaglia, F.L., Nowak, K.J., Stell, R., Phillips, B.A., Edmondston, J.E., Dorosz, S.M., Wilton, S.D., Hallmayer, J., Kakulas, B.A. and Laing, N.G. (1999) Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. Journal of Neurology, Neurosurgery & Psychiatry, 67 (2). pp. 174-179.

Wilton, S.D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S. and Kole, R. (1999) Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromuscular Disorders, 9 (5). pp. 330-338.

Schatzberg, S., Olby, N., Steingold, S., Keene, B., Atkins, C., Meurs, K., Solomon, G., Goedegebuure, S.A., Wilton, S. and Sharp, N. (1999) A polymerase chain reaction screening strategy for the promoter of the canine dystrophin gene. American Journal of Veterinary Research, 60 (9). pp. 1040-1046.

Schatzberg, S.J., Anderson, L.V.B., Wilton, S.D., Kornegay, J.N., Mann, C.J., Solomon, G.G. and Sharp, N.J.H. (1998) Alternative dystrophin gene transcripts in golden retriever muscular dystrophy. Muscle & Nerve, 21 (8). pp. 991-998.

Wilton, S.D., Honeyman, K., Fletcher, S. and Laing, N.G. (1998) Snapback SSCP analysis: Engineered conformation changes for the rapid typing of known mutations. Human Mutation, 11 (3). pp. 252-258.

Wilton, S.D., Lim, L., Dye, D. and Laing, N. (1997) Bandstab: A PCR-based alternative to cloning PCR products. BioTechniques, 22 (4). pp. 642-645.

He, K., Murphy, M.P., Tate, M.L. and Wilton, S.D. (1997) Characterization of the erythrocyte superoxide dismutase allozymes in the deer Cervus elaphus. Animal Genetics, 28 (4). pp. 299-301.

Wilton, S.D., Dye, D.E. and Laing, N.G. (1997) Dystrophin gene transcripts skipping the mdx mutation. Muscle & Nerve, 20 (6). pp. 728-734.

Tan, P., Briner, J., Boltshauser, E., North, K., Davis, M.R., Wilton, S.D., Wallgren-Pettersson, C. and Laing, N.G. (1997) Homozygosity for a nonsense mutation in the alpha-tropomyosin gene TPM3 in a patient with severe nemaline myopathy. Neuromuscular Disorders, 7 (6-7). pp. 427-428.

Pelin, K., Ridanpää, M., Donner, K., Wilton, S., Krishnarajah, J., Laing, N., Kolmerer, B., Millevoi, S., Labeit, S., de la Chapelle, A. and Wallgren-Pettersson, C. (1997) Refined localisation of the genes for nebulin and titin on chromosome 2q allows the assignment of nebulin as a candidate gene for autosomal recessive nemaline myopathy. European Journal of Human Genetics, 5 (4). pp. 229-234.

Wilton, S.D., Dye, D.E., Blechynden, L.M. and Laing, N.G. (1997) Revertant fibres: A possible genetic therapy for Duchenne muscular dystrophy? Neuromuscular Disorders, 7 (5). pp. 329-335.

Tan, P., Allen, J.G., Wilton, S.D., Akkari, P.A., Huxtable, C.R. and Laing, N.G. (1997) A splice-site mutation causing ovine McArdle's disease. Neuromuscular Disorders, 7 (5). pp. 336-342.

Fabian, V.A., Jones, T.M., Wilton, S.D., Dench, J.E., Davis, M.R., Lim, L. and Kakulas, B.A. (1996) Alzheimer's disease and apolipoprotein E genotype in Western Australia: An autopsy-verified series. Medical Journal of Australia, 165 (2). pp. 77-80.

Kakulas, B.A., Wilton, S.D., Fabian, V.A. and Jones, T.M. (1996) Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease. The Lancet, 348 (9025). p. 483.

Wilton, S.D., Lim, L., Dorosz, S.D., Gunn, H.C., Eyre, H.J., Callen, D.F. and Laing, N.G. (1996) Assignment of the human alpha-tropomyosin gene TPM4 to band 19p13.1 by fluorescence in situ hybridization. Cytogenetics and Cell Genetics, 72 (4). pp. 294-296.

Stanton, J.L., Wilton, S.D. and Laing, N.G. (1996) Characterisation of the chicken Cu, Zn superoxide dismutase gene. Mitochondrial DNA, 6 (6). pp. 357-360.

Wilton, S. and Lim, L. (1996) Long-range PCR: Synthesis of products independent of size. Trends in Genetics, 12 (11). p. 458.

Bartlett, R.J., Winand, N.J., Secore, S.L., Singer, J.T., Fletcher, S., Wilton, S., Bogan, D.J., Metcalf-Bogan, J.R., Bartlett, W.T., Howell, J.M., Cooper, B.J. and Kornegay, J.N. (1996) Mutation segregation and rapid carrier detection of X-linked muscular dystrophy in dogs. American Journal of Veterinary Research, 57 (5). pp. 650-654.

Hosler, B.A., Nicholson, G.A., Sapp, P.C., Chin, W., Orrell, R.W., De Belleroche, J.S., Esteban, J., Hayward, L.J., McKenna-Yasek, D., Yeung, L., Cherryson, A.K., Dench, J.E., Wilton, S.D., Laing, N.G., Horvitz, H.R. and Brown, R.H. (1996) Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. Neuromuscular Disorders, 6 (5). pp. 361-366.

Wilton, S.D., Eyre, H., Akkari, P.A., Watkins, H.C., MacRae, C., Laing, N.G. and Callen, D.C. (1995) Assignment of the human a-tropomyosin gene TPM3 to 1q22-->q23 by fluorescence in situ hybridisation. Cytogenetics and Cell Genetics, 68 (1-2). pp. 122-124.

Hunt, C.C., Eyre, H.J., Akkari, P.A., Meredith, C., Dorosz, S.M., Wilton, S.D., Callen, D.F., Laing, N.G. and Baker, E. (1995) Assignment of the human beta tropomyosin gene (TPM2) to band 9p13 by fluorescence in situ hybridisation. Cytogenetics and Cell Genetics, 71 (1). pp. 94-95.

Eyre, H., Akkari, P.A., Wilton, S.D., Callen, D.C., Baker, E. and Laing, N.G. (1995) Assignment of the human skeletal muscle alpha-tropomyosin gene (TPM1) to band 15q22 by fluorescence in situ hybridization. Cytogenetics and Cell Genetics, 69 (1-2). pp. 15-17.

Laing, N.G., Laing, B.A., Meredith, C., Wilton, S.D., Robbins, P., Honeyman, K., Dorosz, S., Kozman, H., Mastaglia, F.L. and Kakulas, B.A. (1995) Autosomal dominant distal myopathy: Linkage to chromosome 14. American Journal of Human Genetics, 56 (2). pp. 422-427.

Langdon, J.S., Masters, A., Thorne, T. and Wilton, S. (1995) Bizarre organism from the skin of mahi mahi, Coryphaena hippurus L. (Teleostei: Coryphaenidae). Journal of Fish Diseases, 18 (6). pp. 481-494.

Wilton, S. and Lim, L. (1995) Rapid identification of ApoE alleles by multiple-single-strand conformation polymorphism (SSCP) analysis. Trends in Genetics, 11 (9). p. 341.

Laing, N.G., Wilton, S.D., Akkari, P.A., Dorosz, S., Boundy, K., Kneebone, C., Blumbergs, P., White, S., Watkins, H., Love, D.R. and Haan, E. (1995) A mutation in the α tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genetics, 9 (1). pp. 75-79.

Akkari, P.A., Eyre, H.J., Wilton, S.D., Callen, D.F., Lane, S.A., Meredith, C., Kedes, L. and Laing, N.G. (1994) Assignment of the human skeletal muscle alpha actin gene (ACTA1) to 1q42 by fluorescence in situ hybridisation. Cytogenetics and Cell Genetics, 65 (4). pp. 265-267.

Wilton, S.D., Chandler, D.C., Kakulas, B.A. and Laing, N.G. (1994) Identification of a point mutation and germinal mosaicism in a duchenne muscular dystrophy family. Human Mutation, 3 (2). pp. 133-140.

Suthers, G., Laing, N., Wilton, S., Dorosz, S. and Waddy, H. (1994) "Sporadic" motoneuron disease due to familial SOD1 mutation with low penetrance. The Lancet, 344 (8939-8940). p. 1773.

Eyre, H.J., Akkari, P.A., Meredith, C., Wilton, S.D., Callen, D.C., Kedes, L. and Laing, N.G. (1993) Assignment of the human slow skeletal muscle troponin gene (TNNI1) to 1q32 by fluorescence in situ hybridisation. Cytogenetics and Cell Genetics, 62 (2-3). pp. 181-182.

Laing, N.G., Laing, B.A., Meredith, C., Wilton, S.D., Mastaglia, F.L., Robbins, P., Honeyman, K., Dorosz, S. and Kakulas, B.A. (1993) Autosomal dominant distal myopathy: linkage to chromosome 14. Clinical Biochemist Reviews, 14 .

Wilton, S.D., Johnsen, R.D., Pedretti, J.R. and Laing, N.G. (1993) Two distinct mutations in a single dystrophin gene: Identification of an altered splice-site as the primary becker muscular dystrophy mutation. American Journal of Medical Genetics Part A, 46 (5). pp. 563-569.

Wilton, S.D., Goldblatt, J. and Laing, N.G. (1993) Verification of carrier status for Becker muscular dystrophy from analysis of a blighted ovum. Prenatal Diagnosis, 13 (8). pp. 757-762.

Laing, N.G., Majda, B.T., Akkari, P.A., Layton, M.G., Mulley, J.C., Phillips, H., Haan, E.A., White, S.J., Beggs, A.H., Kunkel, L.M., Groth, D.M., Boundy, K.L., Kneebone, C.S., Blumberg, P.C., Wilton, S.D., Speer, M.C. and Kakulas, B.A. (1992) Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I. American Journal of Human Genetics, 50 (3). pp. 576-583.

Beggs, A.H., Phillips, H.A., Kozman, H., Mulley, J.C., Wilton, S.D., Kunkel, L.M. and Laing, N.G. (1992) A (CA)n repeat polymorphism for the human skeletal muscle α-actinin gene ACTN2 and its localization on the linkage map of chromosome 1. Genomics, 13 (4). pp. 1314-1315.

Wilton, S. and Cousins, D. (1992) Detection and identification of multiple mycobacterial pathogens by DNA amplification in a single tube. Genome Research, 1 (4). pp. 269-273.

Cousins, D.V., Wilton, S.D., Francis, B.R. and Gow, B.L. (1992) Use of polymerase chain reaction for rapid diagnosis of tuberculosis. Journal of Clinical Microbiology, 30 (1). pp. 255-258.

Laing, N., Majda, B.T., Akkari, A., Clayton, M., Mulley, J., Phillips, H., Haan, E., White, S., Beggs, A., Kunkel, L., Groth, D., Boundy, K., Kneebone, C., Blumbergs, P., Wilton, S., Speer, M. and Kakulas, B. (1991) Assignment of Nemaline Myopathy (Mim 161800, Nem1) to Chromosome-1. Cytogenetics and Cell Genetics, 58 (3-4). p. 1858.

Cousins, D.V., Wilton, S.D. and Francis, B.R. (1991) Use of DNA amplification for the rapid identification of Mycobacterium bovis. Veterinary Microbiology, 27 (2). pp. 187-195.

Gregg, K., Wilton, S.D., Parry, D.A. and Rogers, G.E. (1984) A comparison of genomic coding sequences for feather and scale keratins: Structural and evolutionary implications. The EMBO Journal, 3 (1). pp. 175-178.

Conference Paper

Gregg, K., Wilton, S.D., Rogers, G.E. and Molloy, P.L. (1982) Avian keratin genes: Organisation and evolutionary Inter-relationships. In: 12th International Congress of Biochemistry: Manipulation of Genes in Eukaryotes, 9 - 13 August 1982, Monash University, Melbourne

Conference Item

Pitout, I., Fletcher, S., Etherington, S.ORCID: 0000-0002-6589-8793 and Wilton, S. (2015) A spanner in the works of human Transformer-2-β1 autoregulation may reduce the severity of spinal muscular atrophy. In: 9th Australasian Gene and Cell Therapy Society meeting, 29 April - 1 May, Parkville, Victoria, Australia.

Fletcher, S., Adams, A.M., Greer, K., Johnsen, R. and Wilton, S.D. (2014) Antisense mediated exon selection to alter gene expression. In: PAG Asia 2014, 19 - 21 May 2014, Singapore.

Wilton, S. and Fletcher, S. (2014) Personalised genetic medicines for inherited disorders. In: 5th FIP Pharmaceutical Sciences World Congress (FIP PSWC) 2014: Pharmaceutical Sciences Beyond 2020, 13 - 16 April 2014, Melbourne, VIC.

Wilton, S.D. and Fletcher, S. (2014) Personalised genetic medicines: Hope and Hype. In: The AICC(WA) Murdoch University Science and Society Event, 21 August 2014, Perth, Western Australia.

Wilton, S.D. and Fletcher, S. (2014) Therapeutic alternative splicing: Opportunities and challenges. In: ComBio 2014, 28 September - 2 October, Canberra, ACT, Australia.

Fletcher, S., Viola, H.M., Adams, A.M., Wilton, S.D. and Hool, L.C. (2013) PMO-mediated dystrophin exon 23 skipping restores nitochondrial function in the MDX heart. In: 8th Australasian Gene Therapy Society Meeting, 8 - 10 May 2013, Sydney, Australia.

Wilton, S.D. and Fletcher, S. (2013) Remarkable clinical trials on boys suffering from Duchene Muscular Dystrophy. In: Guest Presentation. Rotary Club of West Perth, 21 Feb 2013, Perth, Western Australia.

Fletcher, S., Adams, A.M., Greer, K., Johnsen, R.D., Adkin, C. and Wilton, S.D. (2012) G.P.78 Dystrophin isoforms with incomplete β dystroglycan and syntrophin binding domains retain partial function. In: 17th International Congress of The World Muscle Society, 9 - 13 October 2012, Perth, Western Australia.

Wilton, S.D., Adams, A.M., Adkin, C., Greer, K., Johnsen, R. and Fletcher, S. (2011) Transient mouse models for the preclinical evaluation of therapeutic dystrophin exon skipping strategies. In: UK Neuromuscular Translational Research Conference, 29 - 30 March 2011, London, England.

Fletcher, S., Adams, A.M., Adkin, C., Greer, K., Johnsen, R. and Wilton, S. (2011) Transient mouse models for the preclinical evaluation of therapeutic dystrophin exon skipping strategies. In: 7th Australasian Gene Therapy Society Meeting, 4 - 6 May 2011, University of Melbourne, Melbourne.

Fletcher, S., Adams, A.M., Johnsen, R.D., Greer, K., Mitrpant, C., Moulton, H.M., Kole, R. and Wilton, S.D. (2010) Concurrent administration of prednisolone and peptide conjugated PMOs is not contra-indicated in the MDX mouse. In: 15th International Congress of The World Muscle Society, 12 - 16 October 2010, Kumamoto, Japan.

Wilton, S.D., Fletcher, S. and Mastaglia, F.L. (2010) Evaluating new therapies & clinical trials: Why, when, which treatment and what benefit? In: MD2010 Conference: Connect, Learn, Share, 9 - 10 September 2010, Perth, Western Australia.

Wilton, S.D. and Fletcher, S. (2010) Implementation of splice switching therapies for duchenne muscular dystrophy. In: OzBio, 26 September - 1 October, Melbourne, Australia.

Fletcher, S., Adams, A.M., Greer, K., Johnsen, R. and Wilton, S.D. (2010) Induced splice-switching to study dystrophin isoform function and expression. In: OzBio, 26 September - 1 October, Melbourne, Australia.

Mitrpant, C., Fragall, C., Fletcher, S. and Wilton, S.D. (2009) Antisense oligomer induced splice manipulation of Survival Motor Neuron exon 7. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Greer, K., Johnsen, R., Wilton, S. and Fletcher, S. (2009) Exceptions to the reading frame rule in DMD: Will exon skipping be relevant? In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Meloni, P., Stone, L., Fletcher, S. and Wilton, S. (2009) Exon skipping strategies to address DMD-Causing mutations: Personalised genetic therapies. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Meloni, P., Johnsen, R., Greer, K., Forrest, S., Stone, L., Fletcher, S. and Wilton, S. (2009) Exon skipping strategies to address DMD-causing mutations: Personalized genetic therapies. In: 33rd HGSA Annual Scientific Meeting, 3 - 6 May 2009, Fremantle, Western Australia.

Forrest, S., Meloni, P., Fletcher, S. and Wilton, S. (2009) Exon skipping therapies to address DMD-causing mutations targeting exon blocks. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Fletcher, S., Adams, A.M., Johnsen, R., Greer, K. and Wilton, S. (2009) Induced non-productive splicing to study muscle gene expression. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Fletcher, S., Adams, A.M., Johnsen, R., Greer, K. and Wilton, S. (2009) Induced non-productive splicing to study muscle gene expression. In: 33rd HGSA Annual Scientific Meeting, 3 - 6 May 2009, Fremantle, Western Australia.

Adams, A.M., Fletcher, S., Ly, T., Johnsen, R. and Wilton, S. (2009) Normalisation of gene expression in MDX mice muscle. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Barrett, L., Pinniger, G., Fall, A.M., Fletcher, S. and Wilton, S.D. (2009) Optimisation of antisense oligonucleotide cocktails using in silico and in vitro techniques for targeted exon skipping in the dystrophin central rod domain. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Wilton, S., Adams, A.M., Meloni, P., Johnsen, R., Forrest, S., Greer, K., Stone, L., Mitrpant, C. and Fletcher, S. (2009) Splice intervention to treat duchenne muscular dystrophy and beyond. In: 33rd HGSA Annual Scientific Meeting, 3 - 6 May 2009, Fremantle, Western Australia.

Wilton, S. and Fletcher, S. (2009) Splice switching therapies as personalised genetic treatments: Applications to muscular dystrophy, thalassemia and spinal muscular atrophy. In: 6th Australasian Gene Therapy Society Meeting, 29 April - 1 May 2009, Kerry Packer Education Centre. Royal Prince Alfred Hospital, Sydney, NSW.

Adams, A.M., Fletcher, S., Ly, T., Johnsen, R. and Wilton, S. (2009) Transcriptome patterns show normalization of muscle gene expression after restoration of dystrophin in MDX mice by exon skipping. In: 33rd HGSA Annual Scientific Meeting, 3 - 6 May 2009, Fremantle, Western Australia.

Mitrpant, C., Fletcher, S., Meredith, C., Bittles, A. and Wilton, S. (2007) Antisense induced exon skipping restores dystrophin in the 4CV mouse model of muscular dystrophy. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Steinhaus, J., Fletcher, S., McKitrick, D.J., Holobotovsky, V., Arnolda, L. and Wilton, S. (2007) Antisense oligonucleotide delivery to cardiac muscle: Knocking on a locked door. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Adams, A.M., Harding, P.L., Iversen, P.L., Coleman, C., Fletcher, S. and Wilton, S.D. (2007) Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: Cocktails and chemistries. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Wilton, S.D., Adams, A.M., Harding, P.L., McClorey, G., Coleman, C. and Fletcher, S. (2007) Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Fletcher, S., Honeyman, K., Fall, A.M., Harding, P.L., Johnsen, R.D., Steinhaus, J.P., Moulton, H.M., Iversen, P.L. and Wilton, S.D. (2007) Exon skipping prevents the onset of dystrophic pathology in the MDX mouse. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Adams, A.M., McClorey, G., Moulton, H.M., Inversen, P.L., Rasko, J.E., Ryan, M., Fletcher, S. and Wilton, S.D. (2007) Induced dystrophin exon skipping in human muscle explants. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Harding, P.L., Adams, A.M., Iversen, P., Fletcher, S. and Wilton, S.D. (2007) Induced exon skipping: AO design is more important than chemistry. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Fletcher, S., Adams, A.M., Harding, P.L., McClorey, G., Muntoni, F., Iversen, P.L. and Wilton, S.D. (2007) A personalised genetic treatment for DMD. In: 5th Australasian Gene Therapy Society Meeting, 18 - 20 April 2007, Shine Dome Academy of Science, Canberra.

Wilton, S.D. and Fletcher, S. (2005) Antisense induced redirection of splicing: Will duchenne muscular dystrophy be the thin edge of the wedge? In: 4th Australasian Gene Therapy Society Meeting, 27 - 29 April 2005, Rydges Hotel, Carlton, VIC.

Harding, P.L., Fletcher, S. and Wilton, S.D. (2005) Antisense oligonucleotides and Exon Skipping: Does size matter? In: 4th Australasian Gene Therapy Society Meeting, 27 - 29 April 2005, Rydges Hotel, Carlton, VIC.

Johnson, C., Wilton, S. and Fletcher, S. (2005) In vitro modification of Tissue-Specific alternative splicing of the mouse TPM3 gene with antisense oligonucleotides. In: 4th Australasian Gene Therapy Society Meeting, 27 - 29 April 2005, Rydges Hotel, Carlton, VIC.

Fletcher, S., Honeyman, K., Fall, A., Harding, P., Johnsen, R. and Wilton, S. (2005) In vivo restoration of dystrophin expression. In: 4th Australasian Gene Therapy Society Meeting, 27 - 29 April 2005, Rydges Hotel, Carlton, VIC.

Fall, A.M., Honeyman, K., Errington, S.J., Fletcher, S. and Wilton, S.D. (2005) Induction of revertant fibres in the mdx Mouse using antisense oligonucleotides. In: 4th Australasian Gene Therapy Society Meeting, 27 - 29 April 2005, Rydges Hotel, Carlton, VIC.

Gibbs, M., Bouwer, S., Johnson, C., Fletcher, S. and Wilton, S. (2005) A comprehensive mutation screening strategy of the dystrophin gene of DMD patients preceding antisense oligoribonucleotide clinical trials. In: 4th Australasian Gene Therapy Society Meeting, 27 - 29 April 2005, Rydges Hotel, Carlton, VIC.

Gebski, B.L., Mann, C.J., Fletcher, S. and Wilton, S.D. (2003) Morpholino antisense oligonucleotides for inducing exon skipping. In: 3rd Meeting of Australasian Gene Therapy Society, 30 April - 2 May 2003, Queensland Institute of Medical Research, Brisbane.

Errington, S.J., Mann, C.J., Fletcher, S. and Wilton, S.D. (2003) Multiple exon skipping in the dystrophin gene: A more effective therapy? In: 3rd Meeting of Australasian Gene Therapy Society, 30 April - 2 May 2003, Queensland Institute of Medical Research, Brisbane.

Wilton, S.D., Mann, C.J., McClorey, G., Honeyman, K., Gebski, B.L., Errington, S.J., Saxena, A. and Fletcher, S. (2003) Redirecting dystrophin pre-mRNA splicing using antisense oligonucleotides: An overview. In: 3rd Meeting of Australasian Gene Therapy Society, 30 April - 2 May 2003, Queensland Institute of Medical Research, Brisbane.

Martino, D., Fletcher, S., Grounds, M. and Wilton, S.D. (2003) Transient suppression of the Myostatin gene transcript: A comparison of different antisense nucleic acid mechanisms. In: 3rd Meeting of Australasian Gene Therapy Society, 30 April - 2 May 2003, Queensland Institute of Medical Research, Brisbane.

Fletcher, S., Ly, T., Duff, R.M., Howell, J.M., Mann, C.J. and Wilton, S.D. (2001) Cryptic splicing involving the splice site mutation in the canine model of Duchenne Muscular Dystrophy. In: 2nd Meeting of the Australasian Gene Therapy Society, 27 - 29 April 2001, Sydney, Australia.

Howell, J.Mc.C., Pari, G., Fletcher, S., Wilton, S., Davies, L.J., Lloyd, F., Nalbantoglu, J., Collins, T.ORCID: 0000-0003-4597-0812, DiMauro, S., Kakulas, B.A. and Karpati, G. (2001) Gene therapy trials in the ovine model of McArdle's disease. In: 2nd Meeting of the Australasian Gene Therapy Society, 27 - 29 April 2001, Sydney, Australia.

Mann, C.J., Ly, T., Fletcher, S., Cheng, A.J., Lloyd, F.P., Morgan, J., Partridge, T. and Wilton, S.D. (2001) Restoration of dystrophin expression in the MDX mouse using antisense oligonucleotides in a gene "knock-in" approach. In: 2nd Meeting of the Australasian Gene Therapy Society, 27 - 29 April 2001, Sydney, Australia.

Howell, J.M., Pari, G., Davies, L., Fletcher, S., Wilton, S.D., Collins, T.ORCID: 0000-0003-4597-0812, Crerar, M.M., Nalbantoglu, J., Shoubridge, E., Jani, A., Tsujino, S., Shankse, S., Kakulas, B.A., DiMauro, S. and Karpati, G. (1999) Investigations of gene therapy for McArdle's disease using the sheep model. In: 4th International Congress of the World Muscle Society, 14 - 16 October 1999, Antalya, Turkey.

Laing, N.G., Mastaglia, F.L., Fabian, V., Jacob, R., Davis, M.R., Wilton, S.D., Morling, P., Papadimitriou, J.M., Valentine, J. and Kakulas, B.A. (1998) Genetic studies in a family with autosomal dominant rod and core disease. In: 3rd International Congress of World Muscle Society, 29 - 30 May 1998, Naples, Italy.

Lu, Q.L., Morris, G.E., Wilton, S.D., Strong, P. and Partridge, T. (1998) Massive idiosyncratic exon loss corrects nonsense mutation in dystrophic mouse muscle and produces functional revertant fibres by clonal expansion. In: IX International Congress on Neuromuscular Diseases, 30 August - 4 September 1998, Adelaide, South Australia.

Nowak, K., Walsh, P., Jacob, R., Johnsen, R., Wilton, S., Kakulas, B. and Laing, N. (1998) Novel gamma-sarcoglycan missense mutation in sisters with muscular dystrophy. In: 3rd International Congress of World Muscle Society, 29 - 30 May 1998, Naples, Italy.

Wilton, S., Carville, K., Schatzberg, S., Honeyman, K., Lloyd, F. and Sharp, N. (1998) Revertant fibres: Dystrophin synthesis despite nonsense or prameshift mutations on the dystrophin gene. In: IX International Congress on Neuromuscular Diseases, 30 August - 4 September 1998, Adelaide, South Australia.

Wilton, S.D., Lloyd, F., Fletcher, S. and Kole, R. (1998) Targeted dystrophin gene processing using antisense oligonucleotides. In: 3rd International Congress of World Muscle Society, 29 - 30 May 1998, Naples, Italy.

Schatzberg, S., Olby, N., Steingold, S., Wilton, S., Dickens, H., Breen, M. and Sharp, N. (1998) The molecular basis of German Short-Haired Pointer (GSHP) muscular dystrophy. In: IX International Congress on Neuromuscular Diseases, 30 August - 4 September 1998, Adelaide, South Australia.

Wilton, S.D., Honeyman, K., Davis, M., Lim, L., Kelloway, L. and Fabian, V. (1997) ApoE genotyping of archival specimens by multiplex SSCP analysis. In: XIII International Congress of Neuropathology, 7 - 12 September 1997, Perth, Australia.

Fabian, V.A., Jones, T.M., Wilton, S.D., Dench, J.E., Davis, M.R. and Kakulas, B.A. (1997) Apolipoprotein-E genotype and Alzheimer's disease in a post mortem series. In: Human Genetics Society of Australasia. 21st Annual Scientific Meeting. Human Genetics: Diversity and Disease, 21 - 25 July 1997, Perth, Western Australia.

Johnsen, R.D., Harker, N.A., Wilton, S.D., Silberstein, E.P., Laing, N.G. and Kakulas, B.A. (1997) Diagnosis of inherited myopathies by molecular methods. In: XIII International Congress of Neuropathology, 7 - 12 September 1997, Perth, Australia.

Tan, P., Briner, J., Boltshauser, E., North, K., Davis, M.R., Wilton, S.D., Wallgren-Pettersson, C. and Laing, N.G. (1997) Homozygosity for a nonsense mutation in the alpha-tropomyosin gene TPM3 in a patient with severe nemaline myopathy. In: 2nd International Congress of the World Muscle Society, 16 - 18 October 1997, Tunis, Tunisia.

Tan, P., Briner, J., Boltshauser, E., Davis, M.R., Wilton, S.D., Wallgren-Pettersson, C. and Laing, N.G. (1997) Homozygous alpha-tropomyosin (TMP3) nonsense mutation in fatal congenital nemaline myopathy. In: Human Genetics Society of Australasia. 21st Annual Scientific Meeting. Human Genetics: Diversity and Disease, 21 - 25 July 1997, Perth, Western Australia.

Edmonston, J., Wilton, S., Kakulas, B. and Laing, N. (1997) Molecular diagnosis of familial amytrophic lateral sclerosis. In: XIII International Congress of Neuropathology, 7 - 12 September 1997, Perth, Australia.

McCluskey, M., Wilton, S.D., Dworniczak, B., Schiavello, T., Thomas, M., Bittles, A.H. and Kaladjieva, L. (1997) Mutation detection in the polycystic kidney disease (PKD1) gene. In: Human Genetics Society of Australasia. 21st Annual Scientific Meeting. Human Genetics: Diversity and Disease, 21 - 25 July 1997, Perth, Western Australia.

Wilton, S.D., Honeyman, K., Lloyd, F. and Kole, R. (1997) Revertant fibres: A potential therapy for DMD. In: XIII International Congress of Neuropathology, 7 - 12 September 1997, Perth, Australia.

Carville, K., Mann, C., Schatzberg, S., Sharp, N., Howell, J.Mc.C. and Wilton, S. (1997) Sequence of full-length dystrophin CDNA and several revertant fibres from muscles of golden retriever dogs. In: 8th Annual Combined Biological Sciences Meeting, 15 August 1997, Perth, Western Australia.

Mann, C., Fletcher, S., Carville, K., Schatzberg, S., Sharp, N., McHowell, J. and Wilton, S. (1997) Sequence of full-length dystrophin cDNA and several revertant fibres from muscles of Golden Retriever dogs. In: XIII International Congress of Neuropathology, 7 - 12 September 1997, Perth, Australia.

Tan, P., Briner, J., Boltshauser, E., Davis, M.R., Wilton, S.D., Wallgren-Pettersson, C. and Laing, N.G. (1996) Homozygosity for a nonsense mutation in the alpha-tropomyosin gene TPM3 in a patient with fatal, congenital, nemaline myopathy with intranuclear rods. In: 7th Annual Combined Biological Sciences Meeting, 19 August 1996, Perth, Western Australia.

Laing, N.G., Tan, P., Wilton, S.D., Akkari, P.A., Johnsen, R.D., Sharp, M., Allen, J. and Huxtable, C. (1996) Ovine models of McArdle's disease and muscular dystrophy. In: Gene Therapy Workshop, 30 - 31 May 1996, Australian Neuromuscular Research Institute, Perth, Western Australia.

Wilton, S., Dye, D., Blechynden, L. and Laing, N. (1996) Revertant Fibres: A possible genetic therapy for Duchenne muscular dystrophy. In: Gene Therapy Workshop, 30 - 31 May 1996, Australian Neuromuscular Research Institute, Perth, Western Australia.

Mann, C.J., Fletcher, S., Wilton, S.D. and Howell, J.Mc.C. (1996) Use of the GRMD model to study gene and genetic therapies for muscular dystrophy. In: 7th Annual Combined Biological Sciences Meeting, 19 August 1996, Perth, Western Australia.

Tan, P., Wilton, S.D., Akkari, P.A., Sharp, M., Allen, J., Huxtable, C.R. and Laing, N.G. (1996) A splice-site mutation causing ovine McArdle's disease. In: 1st Congress of the World Muscle Society, 25 - 27 September 1996, London, UK.

Fabian, V.A., Jones, T.M., Wilton, S.D. and Kakulas, B.A. (1995) Apolipoprotein E and Alzheimer's disease. In: Second Asia-Pacific Conference on Medical Genetics and Eijkman Symposium on the Molecular Biology of Disease, 19 - 23 September 1995, Shangri-La Hotel, Jakarta, Indonesia.

Hunt, C.C.J., Eyre, H.J., Akkari, P.A., Meredith, C., Dorosz, S.M., Wilton, S.D., Callen, D.F. and Laing, N.G. (1995) Assignment of the human beta tropomyosin gene (TPM2) to band 9p13 by fluorescence in situ hybridisation. In: 15th Annual Meeting of the Australian Neuroscience Society, 1 - 3 February 1995, Perth, Western Australia.

Wilton, S., Akkari, A., Dorosz, S., Boundy, K., Kneebone, C., Blumberg, P., White, S., Watkins, H., Love, D. and Laing, N.G. (1995) Autosomal dominant nemaline myopathy - positional cloning to a mutation in tropomyosin 3. In: 5th Annual Queenstown Molecular Biology Meeting, 13 - 18 August 1995, Queenstown, New Zealand.

Tan, P., Wilton, S.D., Akkari, P.A., Sharp, M. and Allen, J. (1995) Frameshift mutation in ovine muscular disease. In: 6th Combined Biological Sciences Meeting, Perth, Western Australia.

Laing, N.G., Wilton, S.D., Akkari, P.A., Dorosz, S.M., Gunn, H.C., Hunt, C.C.J., Lim, L., Meredith, C., Baker, E., Eyre, H.J. and Callen, D.F. (1995) Inherited diseases of skeletal and cardiac muscle associated with contractile proteins. In: Human Genetics Society of Australasia. 19th Annual Scientific Meeting: Genes and Development, 4 - 6 September 1995, Brisbane, QLD.

Akkari, A., Wilton, S., Dorosz, S., Callen, D., Eyre, H., Baker, L., Lim, L., Hunt, C. and Laing, N. (1995) Localization of the tropomyosin genes. In: 17th Annual Conference on the Organisation and Expression of the Genome, 13 - 17 February 1995, Erskine House, Lorne, Victoria.

Dench, J., Wilton, S., Yeung, L., Nicholson, G. and Laing, N.G. (1995) Molecular investigations of Cu/Zn superoxide dismutase (SOD1) amyotrophic lateral sclerosis. In: Human Genetics Society of Australasia. 19th Annual Scientific Meeting: Genes and Development, 4 - 6 September 1995, Brisbane, QLD.

Wilton, S., Lim, L. and Kelloway, L. (1995) Rapid identification of Apo E alleles by multiplex SSCP analysis. In: 6th Combined Biological Sciences Meeting, Perth, Western Australia.

Wilton, S., Dye, D. and Laing, N.G. (1995) Revertant Fibres: A possible genetic therapy for duchenne muscular dystrophy. In: Second Asia-Pacific Conference on Medical Genetics and Eijkman Symposium on the Molecular Biology of Disease, 19 - 23 September 1995, Shangri-La Hotel, Jakarta, Indonesia.

Wilton, S., Laing, N.G. and Dye, D. (1995) Revertant fibres: A genetic therapy for duchenne muscular dystrophy? In: 6th Combined Biological Sciences Meeting, Perth, Western Australia.

Fletcher, S., Lim, L., Dye, D. and Wilton, S. (1995) "Snap-back" SSCP: specific introduction of conformational changes for mutation detection. In: 6th Combined Biological Sciences Meeting, Perth, Western Australia.

Dench, J., Wilton, S., Yeung, L., Nicholson, G., Kakulas, B. and Laing, N.G. (1995) Superoxide dismutase (SOD1) mutations in amyotrophic lateral sclerosis (ALS). In: 16th Annual Neuroscience Colloquium of Western Australia, Perth, Western Australia.

Wilton, S., Akkari, A., Boundy, K., Kneebone, C., Blumberg, P., White, S., Watkins, H., Love, D. and Laing, N.G. (1995) An actin-binding site mutation in tropomyosin 3 causing autosomal dominant nemaline myopathy. In: Second Asia-Pacific Conference on Medical Genetics and Eijkman Symposium on the Molecular Biology of Disease, 19 - 23 September 1995, Shangri-La Hotel, Jakarta, Indonesia.

Wilton, S.D., Akkari, A., Dorosz, S., Boundy, K. and Kneebone, C. (1995) An actin-binding site mutation in tropomyosin 3 causing autosomal dominant nemaline myopathy. In: 17th Annual Conference on the Organisation and Expression of the Genome, 13 - 17 February 1995, Erskine House, Lorne, Victoria.

Tan, P., Wilton, S.D., Akkari, P.A., Sharp, M., Allen, J., Huxtable, C. and Laing, N.G. (1995) A splice-site mutation causes ovine McArdle's disease. In: 16th Annual Neuroscience Colloquium of Western Australia, Perth, Western Australia.

Laing, N.G., Dorosz, S.M., Wilton, S.D. and Hurse, P.V. (1993) Age of onset of familial amyotrophic lateral sclerosis is not associated with the normal range in size of the androgen receptor AGC repeats in the patient - preliminary observations. In: International Conference on Clinical Molecular Biology.

Laing, N.G., Dorosz, S.M., Wilton, S.D. and Hurse, P.V. (1993) Identification of another mutation in the SOD1 gene associated with familial amyotrophic sclerosis (FALS). In: International Conference on Clinical Molecular Biology.

Wilton, S.D. and Laing, N.G. (1993) Identification of point mutations in the dystrophin gene for accurate diagnosis of Duchenne and Becker Muscular Dystrophy. In: International Conference on Clinical Molecular Biology.

Wilton, S.D., Davis, M., Lim, L., Harker, N., Fabian, V., Goldblatt, J. and Laing, N.G. An interchromosomal duplication within the dystrophin gene. In: XIII International Congress of Neuropathology, 7 - 12 September 1997, Perth, Australia.

Book Chapter

Greer, K., Fletcher, S. and Wilton, S.D. (2018) Skipping of duplicated dystrophin exons: In Vitro induction and assessment. In: Yokota, T. and Maruyama, R., (eds.) Exon Skipping and Inclusion Therapies. Humana Press, pp. 219-228.

Aaldering, L., Krishnan, S., Fletcher, S., Wilton, S. and Veedu, R. (2016) Aptamers as therapeutic tools in neurological diseases. In: Veedu, R.N., (ed.) Aptamers: Tools for Nanotherapy and Molecular Imaging. Pan Stanford, pp. 151-167.

Adkin, C., Fletcher, S. and Wilton, S.D. (2012) Optimizing Splice-Switching Oligomer Sequences Using 2′-O-Methyl Phosphorothioate Chemistry. In: Aartsma-Rus, A., (ed.) Exon Skipping: Methods and Protocols. Humana Press, pp. 169-188.

Wilton, S.D. and Fletcher, S. (2006) Redirecting splicing to address dystrophin mutations: Molecular By-pass surgery. In: Jeanteur, P., (ed.) Alternative Splicing and Disease. Springer Berlin Heidelberg, pp. 161-197.

Wilton, S.D., Lim, L., Dye, D. and Laing, N.G. (1999) Bandstab: A PCR-based alternative to cloning PCR products. In: Pardee, A.B. and McClelland, M., (eds.) Expression Genetics: Differential Display. Eaton Publishing Co., pp. 371-376.

Book

Barrett, L.W., Fletcher, S. and Wilton, S.D. (2013) Untranslated gene regions and other Non-coding elements: Regulation of eukaryotic gene expression. Springer, Dordrecht, NL.

Creative Output

Wilton, S.D., Murphy, L. and Fletcher, S. (2010) Molecular Bypass. [Television] [Creative Output]

This list was generated on Mon Oct 14 01:03:43 2019 UTC.